Eli Lilly said on Thursday it sued the federal Health Resources and Services Administration (HRSA) over allegedly blocking the company's plan to change the way it offers drug discounts to hospitals.

The aims of the 340B program are important. But, unfortunately, there is little evidence that the program is delivering on ...

Johnson & Johnson seeks to charge 340B-enrolled disproportionate share hospitals full price for Xarelto and Stelara and issue ...

The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain ...

BROCKPORT — Oak Orchard Health plans to expand its behavioral health services in Genesee County, thanks to a $600,000 award ...

Drugmaker Johnson and Johnson is suing the Department of Health and Human Services and the Health Resources and Services Administration for blocking its new 340B rebate model, and is seeking to verify ...

Dale Bell is not a venture capitalist or a construction financier. But he's a new inductee of the National Academy of Public ...

Dr. Ryan Kruis, director of grants and research for the Telehealth Research Program at the Medical University of South Carolina, has been awarded $1.75 million by HRSA to leverage telehealth to ...

President-elect Donald Trump’s nominee would oversee agencies that regulate food, vaccines and medicine and were instrumental ...

The Centers for Medicare & Medicaid Services (CMS) on Nov. 1, 2024, released the calendar year (CY) 2025 Revisions to Payment Policies under ...

Johnson & Johnson on Tuesday sued the Biden administration in a controversy over how it distributes rebates under the federal ...